An exceeded limit was found for the impurity 5-(4'-(azidomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole in batches of the active substance used to manufacture Valzek (Valsartan) tablets. Potential effects: possible toxic effects of the impurity and a health risk to patients.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Valzek tablets from the listed batches; check the batch number on the package and return the product to the pharmacy or consult a doctor or pharmacist.
Withdrawal from the market throughout the country of the specified batches of Valzek medicinal products and granting the decision immediate enforceability; obliging the marketing authorization holder ...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related